HEADER HYDROLASE 17-OCT-22 8ETR TITLE CRYOEM STRUCTURE OF NLRP3 NACHT DOMAIN IN COMPLEX WITH G2394 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NACHT, LRR AND PYD DOMAINS-CONTAINING PROTEIN 3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ANGIOTENSIN/VASOPRESSIN RECEPTOR AII/AVP-LIKE,CATERPILLER COMPND 5 PROTEIN 1.1,CLR1.1,COLD-INDUCED AUTOINFLAMMATORY SYNDROME 1 PROTEIN, COMPND 6 CRYOPYRIN,PYRIN-CONTAINING APAF1-LIKE PROTEIN 1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NLRP3, C1ORF7, CIAS1, NALP3, PYPAF1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS NLRP3, NACHT, INHIBITOR, HYDROLASE EXPDTA ELECTRON MICROSCOPY AUTHOR J.M.MURRAY,M.C.JOHNSON REVDAT 2 23-NOV-22 8ETR 1 JRNL REVDAT 1 02-NOV-22 8ETR 0 JRNL AUTH C.MCBRIDE,L.TRZOSS,D.POVERO,M.LAZIC,G.AMBRUS-AIKELIN, JRNL AUTH 2 A.SANTINI,R.PRANADINATA,G.BAIN,R.STANSFIELD,J.A.STAFFORD, JRNL AUTH 3 J.VEAL,R.TAKAHASHI,J.LY,S.CHEN,L.LIU,M.NESPI,R.BLAKE, JRNL AUTH 4 A.KATEWA,T.KLEINHEINZ,S.SUJATHA-BHASKAR,N.RAMAMOORTHI, JRNL AUTH 5 J.SIMS,B.MCKENZIE,M.CHEN,M.ULTSCH,M.JOHNSON,J.MURRAY, JRNL AUTH 6 C.CIFERRI,S.T.STABEN,M.J.TOWNSEND,C.E.STIVALA JRNL TITL OVERCOMING PRECLINICAL SAFETY OBSTACLES TO DISCOVER ( S )- N JRNL TITL 2 -((1,2,3,5,6,7-HEXAHYDRO- S JRNL TITL 3 -INDACEN-4-YL)CARBAMOYL)-6-(METHYLAMINO)-6,7-DIHYDRO-5 H JRNL TITL 4 -PYRAZOLO[5,1- B ][1,3]OXAZINE-3-SULFONAMIDE (GDC-2394): A JRNL TITL 5 POTENT AND SELECTIVE NLRP3 INHIBITOR. JRNL REF J.MED.CHEM. V. 65 14721 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 36279149 JRNL DOI 10.1021/ACS.JMEDCHEM.2C01250 REMARK 2 REMARK 2 RESOLUTION. 3.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CISTEM, SERIALEM, CTFFIND, COOT, REMARK 3 PHENIX, CISTEM, RELION, RELION, RELION REMARK 3 RECONSTRUCTION SCHEMA : FOURIER SPACE REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : OTHER REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.500 REMARK 3 NUMBER OF PARTICLES : 231263 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8ETR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1000269381. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : NLRP3 NACHT DOMAIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.50 REMARK 245 SAMPLE SUPPORT DETAILS : HOLEY GOLD GRIDS (ULTRAUFOIL 25 REMARK 245 NM R 1.2/1.3) WERE GLOW REMARK 245 DISCHARGED FOR 20 SECONDS USING REMARK 245 A SOLARUS PLASMA CLEANER (GATAN, REMARK 245 PLEASANTON, CA, USA), AND REMARK 245 GRIDS WERE BLOTTED AND PLUNGE REMARK 245 FROZEN IN LIQUID ETHANE USING A REMARK 245 VITROBOT (THERMOFISHER REMARK 245 SCIENTIFIC, WALTHAM, MA), REMARK 245 OPERATING AT 4C, 100 RELATIVE REMARK 245 HUMIDITY, BLOT FORCE 7, AND REMARK 245 WITH A 4 SECOND BLOT TIME. REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NACHT DOMAIN ONLY REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 600.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6400.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 152 REMARK 465 ASP A 153 REMARK 465 ARG A 154 REMARK 465 ASN A 155 REMARK 465 ALA A 156 REMARK 465 ARG A 157 REMARK 465 LEU A 158 REMARK 465 GLY A 159 REMARK 465 GLU A 160 REMARK 465 SER A 161 REMARK 465 VAL A 162 REMARK 465 SER A 163 REMARK 465 ARG A 178 REMARK 465 SER A 179 REMARK 465 GLN A 180 REMARK 465 GLN A 181 REMARK 465 GLU A 182 REMARK 465 ARG A 183 REMARK 465 GLU A 184 REMARK 465 GLN A 185 REMARK 465 GLU A 186 REMARK 465 LEU A 187 REMARK 465 LEU A 188 REMARK 465 ALA A 189 REMARK 465 ILE A 190 REMARK 465 GLY A 191 REMARK 465 LYS A 192 REMARK 465 THR A 193 REMARK 465 LYS A 194 REMARK 465 THR A 195 REMARK 465 CYS A 196 REMARK 465 GLU A 197 REMARK 465 SER A 198 REMARK 465 PRO A 199 REMARK 465 VAL A 200 REMARK 465 SER A 201 REMARK 465 PRO A 202 REMARK 465 ASP A 213 REMARK 465 GLU A 214 REMARK 465 HIS A 215 REMARK 465 SER A 216 REMARK 465 GLN A 452 REMARK 465 PRO A 453 REMARK 465 ARG A 454 REMARK 465 GLY A 455 REMARK 465 GLY A 456 REMARK 465 SER A 457 REMARK 465 GLN A 458 REMARK 465 GLU A 459 REMARK 465 HIS A 460 REMARK 465 GLY A 461 REMARK 465 LEU A 462 REMARK 465 ASP A 513 REMARK 465 CYS A 514 REMARK 465 GLU A 515 REMARK 465 GLU A 539 REMARK 465 LYS A 540 REMARK 465 GLU A 541 REMARK 465 GLY A 542 REMARK 465 ARG A 543 REMARK 465 THR A 544 REMARK 465 ASN A 545 REMARK 465 VAL A 546 REMARK 465 PRO A 547 REMARK 465 GLY A 548 REMARK 465 SER A 549 REMARK 465 ARG A 550 REMARK 465 LEU A 551 REMARK 465 LYS A 552 REMARK 465 LEU A 553 REMARK 465 PRO A 554 REMARK 465 THR A 589 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 177 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 496 CG CD CE NZ REMARK 470 PHE A 502 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NZ LYS A 338 O ALA A 344 2.13 REMARK 500 OH TYR A 443 OG1 THR A 524 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 217 CD GLU A 217 OE1 -0.067 REMARK 500 GLU A 217 CD GLU A 217 OE2 0.078 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 176 -6.54 73.77 REMARK 500 LEU A 341 71.98 51.70 REMARK 500 LYS A 496 10.88 58.00 REMARK 500 ASP A 498 -7.33 74.80 REMARK 500 TYR A 572 -10.65 73.94 REMARK 500 ASP A 648 -9.92 -57.45 REMARK 500 ARG A 675 -2.62 73.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 701 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 233 OG1 REMARK 620 2 ADP A 702 O3B 97.8 REMARK 620 N 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-28596 RELATED DB: EMDB REMARK 900 CRYOEM STRUCTURE OF NLRP3 NACHT DOMAIN IN COMPLEX WITH G2394 DBREF 8ETR A 134 676 UNP Q96P20 NLRP3_HUMAN 134 676 SEQRES 1 A 543 LYS ASP TYR ARG LYS LYS TYR ARG LYS TYR VAL ARG SER SEQRES 2 A 543 ARG PHE GLN CYS ILE GLU ASP ARG ASN ALA ARG LEU GLY SEQRES 3 A 543 GLU SER VAL SER LEU ASN LYS ARG TYR THR ARG LEU ARG SEQRES 4 A 543 LEU ILE LYS GLU HIS ARG SER GLN GLN GLU ARG GLU GLN SEQRES 5 A 543 GLU LEU LEU ALA ILE GLY LYS THR LYS THR CYS GLU SER SEQRES 6 A 543 PRO VAL SER PRO ILE LYS MET GLU LEU LEU PHE ASP PRO SEQRES 7 A 543 ASP ASP GLU HIS SER GLU PRO VAL HIS THR VAL VAL PHE SEQRES 8 A 543 GLN GLY ALA ALA GLY ILE GLY LYS THR ILE LEU ALA ARG SEQRES 9 A 543 LYS MET MET LEU ASP TRP ALA SER GLY THR LEU TYR GLN SEQRES 10 A 543 ASP ARG PHE ASP TYR LEU PHE TYR ILE HIS CYS ARG GLU SEQRES 11 A 543 VAL SER LEU VAL THR GLN ARG SER LEU GLY ASP LEU ILE SEQRES 12 A 543 MET SER CYS CYS PRO ASP PRO ASN PRO PRO ILE HIS LYS SEQRES 13 A 543 ILE VAL ARG LYS PRO SER ARG ILE LEU PHE LEU MET ASP SEQRES 14 A 543 GLY PHE ASP GLU LEU GLN GLY ALA PHE ASP GLU HIS ILE SEQRES 15 A 543 GLY PRO LEU CYS THR ASP TRP GLN LYS ALA GLU ARG GLY SEQRES 16 A 543 ASP ILE LEU LEU SER SER LEU ILE ARG LYS LYS LEU LEU SEQRES 17 A 543 PRO GLU ALA SER LEU LEU ILE THR THR ARG PRO VAL ALA SEQRES 18 A 543 LEU GLU LYS LEU GLN HIS LEU LEU ASP HIS PRO ARG HIS SEQRES 19 A 543 VAL GLU ILE LEU GLY PHE SER GLU ALA LYS ARG LYS GLU SEQRES 20 A 543 TYR PHE PHE LYS TYR PHE SER ASP GLU ALA GLN ALA ARG SEQRES 21 A 543 ALA ALA PHE SER LEU ILE GLN GLU ASN GLU VAL LEU PHE SEQRES 22 A 543 THR MET CYS PHE ILE PRO LEU VAL CYS TRP ILE VAL CYS SEQRES 23 A 543 THR GLY LEU LYS GLN GLN MET GLU SER GLY LYS SER LEU SEQRES 24 A 543 ALA GLN THR SER LYS THR THR THR ALA VAL TYR VAL PHE SEQRES 25 A 543 PHE LEU SER SER LEU LEU GLN PRO ARG GLY GLY SER GLN SEQRES 26 A 543 GLU HIS GLY LEU CYS ALA HIS LEU TRP GLY LEU CYS SER SEQRES 27 A 543 LEU ALA ALA ASP GLY ILE TRP ASN GLN LYS ILE LEU PHE SEQRES 28 A 543 GLU GLU SER ASP LEU ARG ASN HIS GLY LEU GLN LYS ALA SEQRES 29 A 543 ASP VAL SER ALA PHE LEU ARG MET ASN LEU PHE GLN LYS SEQRES 30 A 543 GLU VAL ASP CYS GLU LYS PHE TYR SER PHE ILE HIS MET SEQRES 31 A 543 THR PHE GLN GLU PHE PHE ALA ALA MET TYR TYR LEU LEU SEQRES 32 A 543 GLU GLU GLU LYS GLU GLY ARG THR ASN VAL PRO GLY SER SEQRES 33 A 543 ARG LEU LYS LEU PRO SER ARG ASP VAL THR VAL LEU LEU SEQRES 34 A 543 GLU ASN TYR GLY LYS PHE GLU LYS GLY TYR LEU ILE PHE SEQRES 35 A 543 VAL VAL ARG PHE LEU PHE GLY LEU VAL ASN GLN GLU ARG SEQRES 36 A 543 THR SER TYR LEU GLU LYS LYS LEU SER CYS LYS ILE SER SEQRES 37 A 543 GLN GLN ILE ARG LEU GLU LEU LEU LYS TRP ILE GLU VAL SEQRES 38 A 543 LYS ALA LYS ALA LYS LYS LEU GLN ILE GLN PRO SER GLN SEQRES 39 A 543 LEU GLU LEU PHE TYR CYS LEU TYR GLU MET GLN GLU GLU SEQRES 40 A 543 ASP PHE VAL GLN ARG ALA MET ASP TYR PHE PRO LYS ILE SEQRES 41 A 543 GLU ILE ASN LEU SER THR ARG MET ASP HIS MET VAL SER SEQRES 42 A 543 SER PHE CYS ILE GLU ASN CYS HIS ARG VAL HET MG A 701 1 HET ADP A 702 27 HET WTN A 703 30 HETNAM MG MAGNESIUM ION HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM WTN (6S,8R)-N-[(1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL) HETNAM 2 WTN CARBAMOYL]-6-(METHYLAMINO)-6,7-DIHYDRO-5H-PYRAZOLO[5, HETNAM 3 WTN 1-B][1,3]OXAZINE-3-SULFONAMIDE FORMUL 2 MG MG 2+ FORMUL 3 ADP C10 H15 N5 O10 P2 FORMUL 4 WTN C20 H25 N5 O4 S HELIX 1 AA1 LYS A 134 PHE A 148 1 15 HELIX 2 AA2 LYS A 204 LEU A 208 5 5 HELIX 3 AA3 GLY A 231 SER A 245 1 15 HELIX 4 AA4 LEU A 272 SER A 278 1 7 HELIX 5 AA5 PRO A 286 VAL A 291 1 6 HELIX 6 AA6 ARG A 292 SER A 295 5 4 HELIX 7 AA7 PHE A 304 LEU A 307 5 4 HELIX 8 AA8 GLY A 328 ARG A 337 1 10 HELIX 9 AA9 ARG A 351 VAL A 353 5 3 HELIX 10 AB1 ALA A 354 GLN A 359 1 6 HELIX 11 AB2 SER A 374 PHE A 386 1 13 HELIX 12 AB3 ASP A 388 GLU A 401 1 14 HELIX 13 AB4 ASN A 402 CYS A 409 1 8 HELIX 14 AB5 ILE A 411 SER A 428 1 18 HELIX 15 AB6 THR A 438 LEU A 451 1 14 HELIX 16 AB7 ALA A 464 GLN A 480 1 17 HELIX 17 AB8 GLU A 486 GLY A 493 1 8 HELIX 18 AB9 HIS A 522 TYR A 534 1 13 HELIX 19 AC1 ASP A 557 ASN A 564 1 8 HELIX 20 AC2 LEU A 573 ASN A 585 1 13 HELIX 21 AC3 TYR A 591 LYS A 595 5 5 HELIX 22 AC4 CYS A 598 LYS A 617 1 20 HELIX 23 AC5 SER A 626 MET A 637 1 12 HELIX 24 AC6 GLU A 639 ASP A 648 1 10 HELIX 25 AC7 THR A 659 ASN A 672 1 14 HELIX 26 AC8 CYS A 673 ARG A 675 5 3 SHEET 1 AA1 5 TYR A 255 HIS A 260 0 SHEET 2 AA1 5 ILE A 297 ASP A 302 1 O LEU A 298 N PHE A 257 SHEET 3 AA1 5 SER A 345 THR A 350 1 O SER A 345 N ILE A 297 SHEET 4 AA1 5 THR A 221 GLN A 225 1 N PHE A 224 O ILE A 348 SHEET 5 AA1 5 ARG A 366 GLU A 369 1 O VAL A 368 N GLN A 225 SHEET 1 AA2 2 GLN A 269 SER A 271 0 SHEET 2 AA2 2 ALA A 325 ARG A 327 -1 O GLU A 326 N ARG A 270 SHEET 1 AA3 3 PHE A 484 GLU A 485 0 SHEET 2 AA3 3 PHE A 517 PHE A 520 -1 O TYR A 518 N PHE A 484 SHEET 3 AA3 3 PHE A 508 GLU A 511 -1 N GLN A 509 O SER A 519 LINK OG1 THR A 233 MG MG A 701 1555 1555 1.91 LINK MG MG A 701 O3B ADP A 702 1555 1555 2.34 CISPEP 1 GLY A 316 PRO A 317 0 0.16 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000